These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
33. In situ expression of soluble B7-1 in the context of oncolytic herpes simplex virus induces potent antitumor immunity. Todo T; Martuza RL; Dallman MJ; Rabkin SD Cancer Res; 2001 Jan; 61(1):153-61. PubMed ID: 11196154 [TBL] [Abstract][Full Text] [Related]
34. Herpes simplex virus thymidine kinase gene therapy in experimental rat BT4C glioma model: effect of the percentage of thymidine kinase-positive glioma cells on treatment effect, survival time, and tissue reactions. Sandmair AM; Turunen M; Tyynelä K; Loimas S; Vainio P; Vanninen R; Vapalahti M; Bjerkvig R; Jänne J; Ylä-Herttuala S Cancer Gene Ther; 2000 Mar; 7(3):413-21. PubMed ID: 10766347 [TBL] [Abstract][Full Text] [Related]
35. Genetically engineered vesicular stomatitis virus in gene therapy: application for treatment of malignant disease. Fernandez M; Porosnicu M; Markovic D; Barber GN J Virol; 2002 Jan; 76(2):895-904. PubMed ID: 11752178 [TBL] [Abstract][Full Text] [Related]
36. Induction of antigen-specific immune responses against malignant brain tumors by intramuscular injection of sindbis DNA encoding gp100 and IL-18. Yamanaka R; Xanthopoulos KG DNA Cell Biol; 2005 May; 24(5):317-24. PubMed ID: 15869409 [TBL] [Abstract][Full Text] [Related]
37. Expression of FMS-like tyrosine kinase 3 ligand by oncolytic herpes simplex virus type I prolongs survival in mice bearing established syngeneic intracranial malignant glioma. Barnard Z; Wakimoto H; Zaupa C; Patel AP; Klehm J; Martuza RL; Rabkin SD; Curry WT Neurosurgery; 2012 Sep; 71(3):741-8; discussion 748. PubMed ID: 22653387 [TBL] [Abstract][Full Text] [Related]
38. Selective destruction of gliomas in immunocompetent rats by thymidine kinase-defective herpes simplex virus type 1. Jia WW; McDermott M; Goldie J; Cynader M; Tan J; Tufaro F J Natl Cancer Inst; 1994 Aug; 86(16):1209-15. PubMed ID: 8040888 [TBL] [Abstract][Full Text] [Related]
39. CD8+-dependent CNS demyelination following ocular infection of mice with a recombinant HSV-1 expressing murine IL-2. Osorio Y; La Point SF; Nusinowitz S; Hofman FM; Ghiasi H Exp Neurol; 2005 May; 193(1):1-18. PubMed ID: 15817260 [TBL] [Abstract][Full Text] [Related]
40. Combination vascular delivery of herpes simplex oncolytic viruses and amplicon mediated cytokine gene transfer is effective therapy for experimental liver cancer. Zager JS; Delman KA; Malhotra S; Ebright MI; Bennett JJ; Kates T; Halterman M; Federoff H; Fong Y Mol Med; 2001 Aug; 7(8):561-8. PubMed ID: 11591892 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]